Fox Chase Cancer Center Postdoctoral Fellow Wins AACR-National Ovarian Cancer Coalition Scholar-in-Training Award
PHILADELPHIA (March 23, 2004) -- The American Association for Cancer Research (AACR) has selected Fox Chase postdoctoral associate Shanchun Guo, MD, PhD, of Philadelphia to receive its 2004 AACR-National Ovarian Cancer Coalition Scholar-in-Training Award. The award is given to presenters of meritorious proffered papers on ovarian cancer research.
"The overall goal of my research is to uncover the molecular genetic and protein alterations involved in initiation and development of human cancer," said Guo. "My main objectives are to characterize the genetic changes in cancer cells, and to evaluate normal gene function and pathogenesis of human cancer. Ultimately, knowledge about the molecular basis of tumor will facilitate the establishment of more effective ways to prevent, diagnose and treat cancer."
As part of the award, Guo will receive a complimentary registration to the 95th AACR Annual Meeting in Orlando, Fla., as well as a stipend for meals and travel. Participation in such professional meetings is critical to career development, to collaborative research relationships and to learning about the very latest in cancer research.
Born in Shandong, China, Guo earned his Ph.D. in pathology in 1998 from Beijing Medical University in China. He received his M.S. in pathology at the Third Military Medical University in Chongging, China in 1990 and earned his M.D. in 1987 at Binzhou Medical College in Binzhou, China.
Guo has been a postdoctoral associate at Fox Chase Cancer Center since 2000 and works in the laboratory of molecular geneticist Andrew K. Godwin, Ph.D. Guo has authored numerous papers and abstracts in his short career.
This award is made possible by a grant provided by the National Ovarian Cancer Coalition. The mission of the National Ovarian Cancer Coalition is to raise awareness about ovarian cancer and to promote education about this disease. By dispelling myths and misunderstandings, the coalition is committed to improve the overall survival rate and quality of life for women with ovarian cancer.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.